BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival

作者: Lars A. Akslen , Sabrina Angelini , Oddbjørn Straume , Ingeborg M. Bachmann , Anders Molven

DOI: 10.1111/J.0022-202X.2005.23788.X

关键词:

摘要: Previous studies have shown frequent mutations in the BRAF (V-raf murine sarcoma viral oncogene homolog B1) or NRAS (neuroblastoma RAS [V-ras] homolog) genes cutaneous melanoma, but relationship between these alterations and tumor cell proliferation has not been examined human melanoma. In our study of 51 primary nodular melanomas 18 paired metastases, we found (codon 600, previously denoted 599) 15 tumors (29%) eight metastases (44%). The figures for were 27% 22%, respectively. Mutations mutually exclusive all one case, maintained from through their metastases. Mutations, however, associated with by Ki-67 expression, thickness, microvessel density, vascular invasion, there no differences patient survival. Although are likely to be important initiation maintenance some melanomas, other factors might more significant prognosis subgroups aggressive

参考文章(26)
Marija J. Norusis, SPSS Advanced Statistics 6.1 ,(1995)
Marcia S Brose, Patricia Volpe, Michael Feldman, Madhu Kumar, Irum Rishi, Renee Gerrero, Eugene Einhorn, Meenhard Herlyn, John Minna, Andrew Nicholson, Jack A Roth, Steven M Albelda, Helen Davies, Charles Cox, Graham Brignell, Philip Stephens, P Andrew Futreal, Richard Wooster, Michael R Stratton, Barbara L Weber, None, BRAF and RAS mutations in human lung cancer and melanoma Cancer Research. ,vol. 62, pp. 6997- 7000 ,(2002)
Kari Hemminki, Kamila Czene, Ilari Sauroja, Seppo Pyrhönen, Sabrina Angelini, Rajiv Kumar, Marjo Hahka-Kemppinen, BRAF Mutations in Metastatic Melanoma: A Possible Association with Clinical Outcome Clinical Cancer Research. ,vol. 9, pp. 3362- 3368 ,(2003)
Lena Kanter, Johan Hansson, Anton Platz, Ulrik Ringborg, Katarina Omholt, Sofia Karsberg, Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. Clinical Cancer Research. ,vol. 8, pp. 3468- 3474 ,(2002)
A. S. Yazdi, G. Palmedo, M. J. Flaig, H. Kutzner, C. A. Sander, SP-11 Different frequencies of a BRAF point mutation in melanocytic skin lesions Pigment Cell Research. ,vol. 16, pp. 580- 580 ,(2003) , 10.1034/J.1600-0749.2003.08330.X
Baskaran Govindarajan, Xianhe Bai, Cynthia Cohen, Hua Zhong, Susan Kilroy, Gwendolyn Louis, Marsha Moses, Jack L Arbiser, Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling Journal of Biological Chemistry. ,vol. 278, pp. 9790- 9795 ,(2003) , 10.1074/JBC.M212929200